The World Health Organization (WHO) convened a technical consultation during 1–2 December 2016 to review new evidence on the risk of HIV acquisition with the use of hormonal contraception. The issue was recognized as a critical one, particularly for sub-Saharan Africa, where women have a high lifetime risk of acquiring HIV, hormonal contraceptives constitute a significant component of the contraceptive method mix and unintended pregnancy is a common threat to the well-being and lives of women and girls.
- Published
- 03 March 2017
- From
-
WHO
The antiretroviral (ARV)-containing vaginal ring form of pre-exposure prophylaxis (PrEP) that reduced HIV risk in a major trial does not lower the effectiveness of hormonal birth control. This finding assuages concerns raised by previous research that the non-nucleoside reverse transcriptase inhibitor (NNRTI) class of ARVs has been associated with a lowered effectiveness of some hormonal contraceptives.
- Published
- 16 February 2017
- From
-
Poz
On January 23, President Donald Trump reinstated the Mexico City Policy via presidential memorandum. The policy requires foreign non-governmental organizations (NGOs) to certify that they will not “perform or actively promote abortion as a method of family planning,” using funds from any source (including non-U.S. funds), as a condition for receiving U.S. government global family planning assistance and, as of Jan. 23, 2017, any other U.S. global health assistance.
- Published
- 24 January 2017
- From
-
Kaiser Family Foundation
The president has reinstated a contentious policy that blocks funding to international family-planning organizations unless they agree not to promote abortion.
- Published
- 23 January 2017
- From
-
The Atlantic
Birth control pills and some types of injectable
and implanted contraceptives were not associated with an increased risk of HIV
acquisition in an updated meta-analysis that included
- Published
- 17 August 2016
- By
- Liz Highleyman
The World Health Organization will convene an expert review group later in 2016 to examine the links between the use of various hormonal contraceptive methods and women’s risk of HIV acquisition. The expert review group will assess whether current WHO guidance needs to change in the light of a new review of data, published in AIDS on 9 August 2016, which was commissioned by WHO.
- Published
- 15 August 2016
- From
- World Health Organization
Women in sub-Saharan Africa who use modern contraceptives are more likely to be tested for HIV than those who do not, according to a study published April 25, 2016 in the open-access journal PLOS ONE by Katherine Center from the University of Arizona and colleagues.
- Published
- 27 April 2016
- From
-
Eurekalert Inf Dis
Woman’s Condom achieves WHO/UNFPA prequalification: The Woman’s Condom, a new female condom designed to be easy to use and more acceptable to women and their partners, has been prequalified by the World Health Organization (WHO)/United Nations Population Fund (UNFPA). The approval marks a critical step forward in expanding options for female-initiated dual protection from pregnancy and sexually transmitted infections (STIs), including HIV.
- Published
- 09 March 2016
- From
-
PATH
In order to maximise confidence in its effectiveness, a
vaginal microbicide ring for women would ideally need to be flexible,
translucent and not too slippery, a focus
- Published
- 18 February 2016
- By
- Gus Cairns
The subject of contraception is a hot topic in faith communities, which made for some exciting discussions at the recent International Conference on Family Planning in Indonesia. The conference heard that contrary to popular belief, many faith-based organisations do support family planning as a process that helps improve people’s quality of life. For the first time, around 80 representatives from different faith groups attending the conference spoke of their commitment to continue informing and educating their communities on family planning. The consensus was that it is consistent with faith values, in order to protect the rights of women, children and families.
- Published
- 05 February 2016
- From
-
Key Correspondents
Antiretroviral drug chartA one-page reference guide to the anti-HIV drugs licensed for use in the UK or European Union, with information on formulation, dosing, key side effects and food requirements.
Your next stepsA booklet with information for people who’ve just found
out they have HIV.
Coming soon: news from IAS 2019 05 July 2019The 10th International AIDS Society
conference (IAS 2019) is being held...
Those who are not seen are not heard 01 July 2019A commentary on Optimising the Impact of Key Population Programming...
The fight for access to abortion care in Europe 27 June 2019Access to
sexual and reproductive health and rights includes safe and...